Bourial Abderrahim, Nourallah Laraqui Othmane, Abdillahi Mahamoud Chirwa, Elhani Hiba, Elmjabber Reyzane, Taali Loubna, Anajar Said, Essaadi Mustapha, Snoussi Khalid, Dahbi Zineb, Hajjij Amal
Department of Oto-laryngology, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.
Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health (UM6SS), Casablanca, Morocco.
Clin Med Insights Case Rep. 2024 Nov 7;17:11795476241295723. doi: 10.1177/11795476241295723. eCollection 2024.
Intra-parotid metastasis refers to the spread of cancerous cells from a primary tumor to the lymph nodes within the parotid gland. To our best knowledge, we report the first described case in the literature of a patient who received IMRT for nasopharyngeal carcinoma (UCNT) without sparing the parotid gland and still experienced a recurrence.
A 57-year-old male patient of north African origin presented with a left parotid mass that had been evolving for 6 months. He was previously diagnosed with and treated for nasopharyngeal carcinoma 2 years prior to admission, with Intensity-Modulated Radiotherapy (IMRT) without sparing the parotid gland, as well as chemotherapy. Medical imaging was suggestive of recurrence of nasopharyngeal carcinoma and metastasis due to the patient's medical history. The patient benefited from a total parotidectomy; The histopathological analysis of the surgical specimen confirmed the presence of a poorly differentiated carcinoma (UCNT) with nodal metastasis.
Intensity-Modulated Radiation Therapy (IMRT) holds great promise as an alternative treatment option. However, it should be reserved for specific cases with minimal lymph node involvement, and always preceded by a thorough clinical and radiological examination.
腮腺内转移是指癌细胞从原发肿瘤扩散至腮腺内的淋巴结。据我们所知,我们报告了文献中首例未对腮腺进行保护而接受调强放射治疗(IMRT)的鼻咽癌患者仍出现复发的病例。
一名57岁的北非男性患者出现左侧腮腺肿物,已持续6个月。他在入院前2年曾被诊断为鼻咽癌并接受了调强放射治疗(IMRT),未对腮腺进行保护,同时还接受了化疗。由于患者的病史,医学影像提示鼻咽癌复发及转移。患者接受了全腮腺切除术;手术标本的组织病理学分析证实存在低分化癌(鼻咽癌)伴淋巴结转移。
调强放射治疗(IMRT)作为一种替代治疗选择具有很大的前景。然而,它应仅用于淋巴结受累最少的特定病例,并且始终要先进行全面的临床和放射学检查。